Elorac, Inc. Reports Impressive Results For Scalp Psoriasis Shampoo Trial

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VERNON HILLS, Ill.--(BUSINESS WIRE)--Elorac, Inc. released preliminary results today of their patient-centered Experience Zithranol Shampoo (EZ) Trial. The EZ Trial was designed to collect “real life” data based on patients’ assessment of their experience before and after using the product. After using Zithranol Shampoo from 14-30 days, 93% of patients reported that they would use Zithranol Shampoo again.

Select dermatology offices throughout the country identified patients with scalp psoriasis that had been resistant to standard therapies. Patients were provided Zithranol Shampoo therapy with other documents including a data collection form for them to assess their scalp psoriasis before and after treatment.

Help employers find you! Check out all the jobs and post your resume.

Back to news